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Abstract
Increased neurological soft signs (NSSs) have been found in a number of neuropsychiatric syndromes, including chemical
addiction. The present study examined NSSs related to perceptual-motor and visuospatial processing in a behavioral
addiction viz., pathological gambling (PG). As compared to mentally healthy individuals, pathological gamblers displayed
significantly poorer ability to copy two- and three-dimensional figures, to recognize objects against a background noise,
and to orient in space on a road-map test. Results indicated that PG is associated with subtle cerebral cortical abnormalities.
Further prospective clinical research is needed to address the NSSs’ origin and chronology (e.g., predate or follow the
development of PG) as well as their response to therapeutic interventions and/or their ability to predict such a response.
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Introduction
Parallel to the ongoing expansion of legalized gambling
activities is an increase in the prevalence of pathological gambling
(PG) [1,2]. Pathological gambling afflicts up to 5% of the general
adult population and it costs American society an estimated $54
billion annually due to crime, decreased productivity, and
bankruptcies [3–7]. These estimates are likely conservative, given
that PG is not a conspicuous addiction, and it is devoid of typical
symptoms of intoxication, needle marks, or overdose. It may only
become noticeable in later stages of the illness, with the emergence
of highly visible behaviors including attempted suicide in up to
24% of untreated individuals [7–9]. To improve prevention and
treatment of PG, it is important to identify its behavioral markers
and their neural correlates.
A relatively consistent finding in functional brain imaging
studies of PG is failure of prefrontal cortical areas to activate when
challenged by cognitive tasks that normally evoke cerebral blood
flow and metabolic responses in these regions [10–17]. Likewise,
neuropsychological impairments are commonly documented in
PG patients [18–20], but their role in the course of the disorder
remains unclear [16], as they do not reliably reflect the severity of
gambling problems [21,22]. The nonspecificity of PG neuropsy-
chological findings may be partially attributable to the multidi-
mensionality of the tests employed [23]. Additionally, some results
may reflect poor motivation and attention [24,25] rather than PG-
related primary neuropathology, which has not yet been well
defined [23].
Neurological assessment paradigms may be of value in revealing
cortical abnormalities in PG. In this regard, neurological soft signs
(NSSs) are reliable [26–28], easily administered and temporally
stable [29,30] markers of neurological compromise, which impose
fewer cognitive demands than neuropsychological tests and are
therefore less influenced by performance confounds [31]. In
contrast to hard neurological signs localizable to a specific brain
site, their soft counterparts are attributed to wider brain regions
and functionally connected neuroanatomical systems, involved in
integrative neurological functions such as sensory perception,
coordination and motor sequencing [32,33]. Neurological soft
signs have been observed in a growing number of neuropsychiatric
syndromes including mood disorders [34–36], obsessive-compul-
sive disorder (OCD) [37–39], post-traumatic stress disorder
[26,27], impulse control disorder [40], schizophrenia [32,34,41],
and attention deficit hyperactivity disorder [42]. Furthermore, an
inverse relationship between NSSs scores and total brain volume
has been noted in psychopathological populations [27,43] adding
support to the generalized rather than localized NSSs’ nature.
In a previous paper, we reported that cocaine dependence is
characterized by the NSS of constructional apraxia [31]. As with
PG, cocaine dependence is classified in the DSM-V draft among
Substance Use and Addictive Disorders [44]. However, in
addition to its representing a behavioral addiction, a substance
addiction to cocaine exerts profound chemical effects on the brain
that may even result in such injuries as subarachnoid/parenchy-
mal hemorrhages [45–56] and infarcts [47,50].
Because it is not confounded by exogenous neurotoxicity, PG
offers a unique opportunity to test whether a purely behavioral
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knowledge, NSSs have not yet been investigated in pathological
gamblers. The presence in PG of obsessive/compulsive and
impulsive features each of which has been previously linked with
NSSs [40,57,58] suggests that NSSs may also be seen in PG.
Accordingly, in this project we assessed three NSSs in PG and
healthy subjects. These were: a) copying two- and three-
dimensional figures (as previously tested in cocaine subjects
[31]); b) filtration of visual signal from noise; and c) left-right
orientation in the form of reading and understanding a simple
road map. These visuospatial and sensory integration tasks were
selected for the present project from our comprehensive NSSs
assessment battery based upon their discriminative ability in drug-
dependent and other psychiatric patients [27,31,59] as well as
their ease of administration as paper-and-pencil tasks. We
hypothesized that patients with PG would be more impaired than
healthy subjects on all three tasks.
Methods
Subjects
Twenty-one subjects who met the Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, Text Revision (DSM
IV-TR) criteria for PG, and 10 non-gamblers who did not meet
DSM IV-TR criteria for any disorder, were recruited by
newspaper advertisement for participation in a previous study on
the neurobiology of PG. The biochemical [60] and psychosocial
[61] stress responsivity findings from that study have been
reported elsewhere. After a full explanation of the procedures,
all subjects gave written informed consent to the McLean Hospital
Institutional Review Board-approved protocol. Those with any
cognitive impairment that precluded informed consent based on
clinical interview and the assessments instruments (see below) were
excluded from study participation. Subjects were diagnosed by a
research psychiatrist using a best estimate format utilizing all
available sources of information including clinical history,
interview, and the following psychodiagnostic instruments: the
Structured Clinical Interview for DSM-IV (SCID [62]); the South
Oaks Gambling Screen (SOGS [63]); the DSM PG checklist
(DSMIV-TR [64,65]); and the Addiction Severity Index [66]. All
subjects were right handed as determined by the Edinburgh
Handedness Inventory [67], and scored at least 28 on the Mini
Mental Status Examination (MMSE [68]). Furthermore, they were
in good physical health as ascertained by the Cornell Medical
Index Health Questionnaire [69].
The exclusion criteria included left handedness, lifetime history
of dementia, schizophrenia, or other psychotic disorder, bipolar
disorder, anxiety disorder, current drug or alcohol dependence,
past but not current PG, or major depression with onset prior to
PG. We also excluded potentially confounding neurological
conditions, such as seizure disorder, head trauma accompanied
by loss of consciousness greater than 10 minutes, brain surgery,
multiple sclerosis, and Parkinson’s disease, as well as potentially
confounding medical conditions such as chronic obstructive
pulmonary disease, coronary artery disease, diabetes, obesity
(body mass index $30), congestive heart failure, hypertension,
renal diseases, cirrhosis, HIV-positive status and AIDS. Recent
drug and alcohol consumption was ruled out by negative results on
urine toxicology screen and breathalyzer.
Procedures
The three tasks were administered over one session in the
following order: Copy Figure Test (CFT), Detection and
Recognition of an Object Test (DROT) and Road Map Test
(RMT). None of the tasks was timed. Responses on the DROT
and the RMT were recorded by a research assistant seated next to
the subject. Both the subject and the examiner were ‘blind’ to the
study’s hypothesis.
The CFT [70,71] is perceptual-motor in nature and comprises
two-dimensional (diamond and cross) and three-dimensional
(Necker cube, smoking pipe, hidden line elimination cube,
pyramid and dissected pyramid) figures (Figure 1A). Subjects were
instructed to copy each figure exactly as it appeared to them with a
pen. They were allowed to look at each figure as often as needed.
They were further instructed neither to erase any lines nor to draw
any lines that did not appear in the figure they copied.
The DROT [72,73] consisted of two sets of the same six images
(Figure 2). Each image depicted a single basic household object,
namely key, shovel, pitcher, eyeglasses, hammer, and kettle.
However, the object recognition was complicated by background
‘‘noise,’’ consisting of a field of black squares of two different
densities, namely 35 and 15 squares per line. Subjects viewed all
six objects with the denser (more difficult) background first,
followed by all six objects with the less dense (less difficult)
background. They were instructed to identify all objects and were
allowed to bring the page as close to the eyes as desired.
The RMT [74] is designed to evaluate directional sense in
visuospatial processing (Figure 3). Subjects were presented with a
map of an imaginary town, with a delineated route containing 32
intersections. They were instructed to imagine driving this route
and to indicate at each intersection whether the route turned left
or right. The research assistant followed the route with a pencil
and marked R or L in accordance with the verbal response at each
intersection. The map remained in a fixed position in front of the
subject, and they were not allowed to move it. Each subject’s
familiarity with the task was confirmed via a brief practice trial.
The CFT was scored by a dually trained psychiatrist and
neurologist, who not only was blind to diagnosis but had never
seen the subjects, utilizing a four-point scoring convention for each
figure. Zero (0) coded perfect or near perfect reproduction; 1
coded mild distortion or rotation; 2 coded moderate distortion or
rotation, or severe micropsy or a loss of three-dimensionality; and
3 coded gross distortion of the basic gestalt or a virtually
unrecognizable image. On the DROT, number of failed
identifications was scored. On the RMT, number of wrong turns
was scored.
Demographic variables were analyzed by Student’s t-tests or
Fisher’s exact tests as appropriate. Because most of the CFT,
DROT, and RMT data were ordinal and not normally
distributed, they were summarized as both median and mean 6
standard deviation (SD). The univariate nonparametric Wilcoxon
rank-sum test was used to compare groups. Significance was
defined as p,0.05, one-tailed, with more abnormalities predicted
in the PG group.
Results
Table 1 presents demographic and psychometric data for the
two groups. These data demonstrate that pathological gamblers
were not significantly different from healthy controls with respect
to age, race, gender, years of education, performance on the
MMSE, and consumption of alcohol. As planned, there were
conspicuous differences in SOGS score and the number of DSM-
IV TR PG criteria met.
Figure 1B presents examples of mistakes made by PG subjects
on the CFT. Table 2 presents the group medians and means ±
SDs for each CFT figure separately and for the average score of all
7 figures, as well as the DROT and RMT score means and
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exception of the smoking pipe figure and the pyramid figure (for
which there was a trend), all tests revealed significantly poorer
performance in the PG group. Performance on the hidden line
elimination- and Necker cubes was dramatically poorer in the PG
subjects. Notably, the latter test is characterized by ambiguous
front-back orientation necessitating visuospatial ability to shift
attention between two equally plausible figural spatial represen-
tations [75].
Repeating the analyses after excluding ten smokers (all in the
PG group; among them are two subjects with respective cocaine
and alcohol dependence, both in full sustained remission), the
group effect remained significant for the CFT average score
(p=0.002), for the high (p=0.03) and low (p=0.0005) noise
DROT errors and for the RMT errors (p=0.03).
Discussion
In this study we identified several signs in pathological gamblers
reflecting their diminished ability to recognize and construct
objects and orient them in space. These dysfunctions have not yet
been addressed in literature on neuropsychological disturbances in
PG. In comparison to healthy subjects, pathological gamblers
showed substantially worse performance on copying two- and
three-dimensional figures, recognizing objects against background
noise, and discriminating left from right turns on a map.
Methodological similarities between the present study and our
prior study of cocaine dependence [31] included enrollment of
subjects with addictive disorders and use of a standard copy figure
task. There were differences in the type of addiction and in the
number of tasks performed by subjects. Overall these results
provide further support for subtle neurobiological impairment in a
behavioral addiction that is not confounded by exogenous
chemical use. Our data are also consistent with a substantial body
of literature documenting neuropsychological impairments in PG
patients [18–20], and they extend prior findings by suggesting that
the impairments are not restricted to the cognitive domains
addressed by neuropsychological testing but also generalize to the
sensorimotor domain.
Several brain regions influence the drawing of three-dimen-
sional figures, but as evident from research on cortically damaged
patients [76] and from neuroimaging work [75,77] the most
important of the regions is the parietal cortex. Ventral striatum
and related mesolimbic dopaminergic circuitry are traditionally
considered to be a key component of reward system involved in
addiction [78], and it is commonly hypothesized that changes in
the mesolimbic pathways underlying motivational processes are
responsible for transforming regular drives into heightened
incentive salience assigned to addiction-related cues [79]. How-
ever, recent research suggests a novel factor in the mechanisms
underlying incentive sensitization by implicating parietal cortex in
the control exerted over striatal signals of salience via integration
of visuospatial, motor and cognitive (e.g., hedonic value and
categorical boundaries) inputs [80]. In addition to these theoretical
considerations, an abundant clinical literature demonstrates
parietal cortex changes in the context of chronic addictive
behaviors [81,82]. Hence NSSs examination may support the
Figure 1. The two-dimensional (diamond and cross) and three-dimensional (Necker cube, smoking pipe, hidden line elimination
cube, pyramid and dissected pyramid) figures copied by the subjects (Panel A). Examples of PG subjects’ performance on the Copy
Figure Test (Panel B).
doi:10.1371/journal.pone.0060885.g001
Figure 2. Detection and Recognition of an Object Test (DROT).
‘‘High noise’’ and ‘‘low noise’’ sets were presented separately, with the
latter following the former. Subjects were instructed to identify the
object embedded in the noise.
doi:10.1371/journal.pone.0060885.g002
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pathophysiology of PG.
A limitation of the cross-sectional design employed here is its
inability to resolve the origin of elevated NSSs in PG. One
possibility is that they are preexisting vulnerability markers [83]. A
growing body of work points to compromised cortical function
reflected in NSSs that precedes the emergence of mood, anxiety
[57], psychotic [84–86] and obsessive-compulsive [57,87] symp-
toms. Neurological soft signs are also commonly observed in
mentally healthy relatives of schizophrenic patients [88–91],
further suggesting their preexisting and inheritable trait-like
nature. Notably, as suggested by twin studies, PG has a robust
genetic component ranging from 50 to 60% [92]. Greater
premorbid hyperactivity, impulsivity, and antisociality have been
found in PG subjects [93].
A second possible origin of NSSs in PG is that they are
acquired, e.g., they are a consequence of excessive gambling.
People who gamble lose money, and a consequence of losing
money may be increased stress, possibly leading to brain
alterations. Pathological gambling is indeed associated with an
exaggerated sympathoadrenal tone suggestive of heightened levels
of stress and arousal [94] at baseline [95,96] and while engaged in
gambling [8,9,97–100]. Subjects with PG have greater amygdala
activation in response to the alpha-2 adrenergic antagonist,
yohimbine [60]. Research in laboratory animals [101] and
humans [102,103] has shown that increased sympathetic activity
may cause vasospasm and microthrombosis resulting in dimin-
ished cerebral perfusion. It would be of interest to test whether
antiadrenergic agents (e.g., clonidine or prazosin) might moderate
the NSSs observed here. However, the reversibility of NSSs is
questionable [39], given that this has only been found in some
[104] but not in all OCD patients [105–107], and not in patients
with bipolar disorder [108] or schizophrenia [107,109]. In sum,
resolution of the risk factor vs. acquired origin interpretation of the
observed NSSs in PG, as well as NSSs’ possible response to
treatment and/or their ability to predict [37,110] such a response
(as has been shown for OCD patients) will require prospective
clinical trials.
The present design is unable to inform the question as to
whether the same visual agnosia displayed by the PG subjects on
the DROT is not likewise implicated in their constructional
apraxia on the figure copying task. Disentangling this would
require an exclusively motor processing task that does not involve
visual input [27]. Such tasks are included in the full assessment
battery of previously reported NSSs [27], which assesses motor
coordination and both motor and sensory integration.
In conclusion, the data presented here shed light on the
neurological function of patients with PG and suggest that NSS
examination has heuristic value for illuminating brain abnormal-
ities in this disorder. Pathological gambling offers a unique model
as it represents an addictive behavior in the absence of the
Figure 3. The Money Road Map Test (RMT). The continuous
dotted line represents the path followed by the researcher’s pen.
Subjects were asked at each successive turn to indicate whether it was
right or left. The smaller dotted line in the lower right serves as a
practice trial.
doi:10.1371/journal.pone.0060885.g003
Table 1. Demographic and Clinical Characteristics (Means 6
SDs or Ratios) of Study Participants.
Variable PG (n=21)
Control
(n=10) T-test (df=29)
t p
Age (year) 45.569.9 43.6614.2 0.44 0.66
Education (year) 15.062.8 15.161.4 20.16 0.88
MMSE (score) 29.360.9 29.461.1 20.19 0.86
Alcohol (drink/week) 1.063.0 0.661.3 0.44 0.66
DSM-IV-TR PG criteria met 7.361.2 0.060.0
SOGS 13.563.8 0.060.0
Fisher’s exact test
Gender (M/F) 13/8 5/5 0.74
Race (W/B) 10/11 7/3 0.72
doi:10.1371/journal.pone.0060885.t001
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chemical substances. Therefore these findings provide a new
perspective in the exploration of addiction neurobiology.
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